CytomX Therapeutics, Inc.

CTMX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.9B · 69 employees
210
SEC Filings
$2.765
Close 2026-09-16
69
Employees

Business Summary

CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing conditionally activated, masked biologics using its PROBODY technology platform. The platform masks biologic therapeutics until tumor-associated proteases remove the mask in the tumor microenvironment. Its lead program, Varseta-M (varsetatug masetecan), is an EpCAM-targeting ADC in Phase 1 for metastatic colorectal cancer. CX-801 is a second clinical program. The company licenses payload technology from AbbVie (formerly ImmunoGen).

Latest Stock Quote

CTMX 2026-09-16 $2.765 O:$2.72 H:$2.865 L:$2.6709 Vol:6.9M VWAP:$2.7655
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-08

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001193125-26-107146EDGAR99K words
2025-03-062024-12-310000950170-25-034575EDGAR94K words
2024-03-112023-12-310000950170-24-029191EDGAR95K words
2023-03-272022-12-310000950170-23-009991EDGAR102K words
2022-03-012021-12-310000950170-22-002519EDGAR—
2021-02-242020-12-310001564590-21-008081EDGAR—
2020-02-272019-12-310001564590-20-007395EDGAR—
2019-02-272018-12-310001564590-19-004890EDGAR—
2018-03-072017-12-310001564590-18-004727EDGAR—
2017-03-022016-12-310001564590-17-003229EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001193125-26-337950EDGAR61K words
2025-11-062025-09-300001193125-25-269477EDGAR61K words
2025-08-072025-06-300000950170-25-104991EDGAR59K words
2025-05-122025-03-310000950170-25-068511EDGAR58K words
2024-11-072024-09-300000950170-24-123249EDGAR61K words
2024-08-082024-06-300000950170-24-093865EDGAR60K words
2024-05-082024-03-310000950170-24-055588EDGAR58K words
2023-11-072023-09-300000950170-23-060201EDGAR62K words
2023-08-082023-06-300000950170-23-039761EDGAR60K words
2023-05-092023-03-310000950170-23-019654EDGAR58K words
2022-11-082022-09-300000950170-22-023190EDGAR—
2022-08-042022-06-300000950170-22-014737EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001193125-26-338009EDGAR3K words
2026-07-270001193125-26-316929EDGAR1K words
2026-03-190001193125-26-115958EDGAR29K words
2026-03-160001193125-26-107152EDGAR3K words
2025-11-060001193125-25-269533EDGAR3K words
2025-08-130001193125-25-179463EDGAR1K words
2025-08-070000950170-25-105053EDGAR3K words
2025-06-130001193125-25-140739EDGAR9K words
2025-05-280001193125-25-129470EDGAR1K words
2025-05-130001193125-25-118805EDGAR19K words

210 total filings indexed. 178 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology colorectal-cancer solid-tumors metastatic-cancer recist-v1.1 immunohistochemistry-(ihc)-for-epcam-expression

Company Identity

CIK0001501989
TickerCTMX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.cytomx.com
Listed2015-10-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 99b41acede3f9022d13b3fb39131467fcb636c56541368f4f1ccd07623a753db
parent: eaa5685d781cc8bb8d5b129f35eba86ed83d56d46a0a98ec57db457c31291886
content hash: 447f3841fe1f4895e804e253f97d34769f7861c41b23f38640505c03008364c7
signed: 2026-09-29T19:00:53.514Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CTMX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CTMX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CTMX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.